Ruth Devenyns, CEO

Ms. Devenyns has over 25 years of experience in the financial industry in both investment banking and venture capital in the healthcare sector. Prior to joining Precirix as CEO in 2017, she was CFO of Ogeda, a Belgium-based clinical-stage drug discovery company, until their acquisition by Astellas Pharma Inc. Ms. Devenyns has a master’s in applied economics from the University of Ghent.

Your browser is not supported. Update your browser for more security, speed and to make the most of this site.